CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly licensed Geenius test is an immunochromatographic assay designed to confirm and differentiate individual antibodies to Human Immunodeficiency Virus Types 1 and 2. The assay will be replacing the HIV-1 Western blot and HIV-2 EIA assays which are performed on samples with a reactive result on a licensed HIV 1/2 screening test.
Read all about it on the Communication page by clicking this link: Communications
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...